Ads
related to: bristol-myers squibb- Savings Card
See If You Are Eligible To Save
On An ELIQUIS Prescription
- Prescribing Info
See Full Prescribing Info
Including Boxed Warning
- Chat With Elise
Get Help From Our
Virtual Assistant, Elise
- ELIQUIS & Safety Info
See Full Safety Info &
Boxed Warning. Learn More
- ELIQUIS HCP Info
Visit the Official US Healthcare
Website for ELIQUIS Safety Info
- Doctor Discussion Guide
Learn More About The Interactive
Eliquis Doctor Discussion Guide
- Savings Card
scbn.org has been visited by 10K+ users in the past month
Search results
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 22 hours agoCytokinetics stock reversed higher Tuesday after safety worries clouded promising study results for...
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 5 days agoAt a time when drugmakers Eli Lilly & Co. and Novo Nordisk are scrambling to meet demand for their...
One stock is dragging down the S&P 500's earnings growth
AOL· 2 days agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings season for the index, with one key exception: drugmaker Bristol Myers Squibb (BMY). Last month ...
One stock is dragging down the S&P 500's earnings growth
Yahoo Finance via AOL· 2 days agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings...
Daily Spotlight: Profit Margins Widened in 1Q
Argus Research via Yahoo Finance· 7 hours agoFirst-quarter earnings season is winding down as the retailers wrap up their reports. The overall growth rate is set to land in the 7%-8% range. That's not bad -- and the rate would be higher ...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 2 days agoBristol Myers Squibb’s (BMS) blockbuster cancer therapies Opdivo (nivolumab) and Yervoy (ipilimumab)...
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
Motley Fool via Yahoo Finance· 3 days agoAbout once every 90 days, publicly traded companies have to face their shareholders and let them...
Large Cap Trio for Value, Growth and Yield
MoneyShow via Yahoo Finance· 2 days agoWith a solid economy and a Fed still likely to cut interest rates this year, we believe the dividend yield of 2.6% and forward P/E ratio of 14 on our portfolio holdings are attractive, especially ...
2 Beaten-Down Stocks to Buy and Hold for 10 Years
The Motley Fool via AOL· 5 days agoIt's easy to find stocks that are lagging broader equities, even in a bull market like the one we're currently in. It's harder to find beaten-down stocks...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill via AOL· 7 days agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
Ad
related to: bristol-myers squibb